Renascience Inc. (TYO:4889)
Japan
· Delayed Price · Currency is JPY 1,817.00
-129.00 (-6.63%)
Jun 27, 2025, 3:30 PM JST
Renascience Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| 132 | 194 | 100 | 139 | 209 | Upgrade
| |
Revenue Growth (YoY) | -31.96% | 94.00% | -28.06% | -33.49% | 190.28% | Upgrade
|
Cost of Revenue | 4 | 29 | - | 59 | 29 | Upgrade
|
Gross Profit | 128 | 165 | 100 | 80 | 180 | Upgrade
|
Selling, General & Admin | 307 | 167 | 185 | 193 | 265 | Upgrade
|
Research & Development | - | 236 | 235 | 82 | - | Upgrade
|
Other Operating Expenses | - | 13 | 13 | 13 | - | Upgrade
|
Operating Expenses | 307 | 417 | 434 | 291 | 265 | Upgrade
|
Operating Income | -179 | -252 | -334 | -211 | -85 | Upgrade
|
Interest Expense | - | - | - | -5 | -7 | Upgrade
|
Currency Exchange Gain (Loss) | -1 | - | - | - | 1 | Upgrade
|
Other Non Operating Income (Expenses) | 1 | -1 | - | -26 | - | Upgrade
|
EBT Excluding Unusual Items | -179 | -253 | -334 | -242 | -91 | Upgrade
|
Asset Writedown | -1 | -4 | - | -11 | - | Upgrade
|
Other Unusual Items | 323 | - | - | - | -9 | Upgrade
|
Pretax Income | 143 | -257 | -334 | -253 | -100 | Upgrade
|
Income Tax Expense | 30 | 1 | 1 | 1 | - | Upgrade
|
Net Income | 113 | -258 | -335 | -254 | -100 | Upgrade
|
Net Income to Common | 113 | -258 | -335 | -254 | -100 | Upgrade
|
Shares Outstanding (Basic) | 13 | 13 | 13 | 11 | 10 | Upgrade
|
Shares Outstanding (Diluted) | 13 | 13 | 13 | 11 | 10 | Upgrade
|
Shares Change (YoY) | - | - | 11.61% | 15.99% | 0.00% | Upgrade
|
EPS (Basic) | 8.89 | -20.30 | -26.35 | -22.30 | -10.18 | Upgrade
|
EPS (Diluted) | 8.89 | -20.30 | -26.35 | -22.30 | -10.18 | Upgrade
|
Free Cash Flow | -176 | -231 | -286 | -231 | - | Upgrade
|
Free Cash Flow Per Share | -13.85 | -18.17 | -22.50 | -20.28 | - | Upgrade
|
Gross Margin | 96.97% | 85.05% | 100.00% | 57.55% | 86.12% | Upgrade
|
Operating Margin | -135.61% | -129.90% | -334.00% | -151.80% | -40.67% | Upgrade
|
Profit Margin | 85.61% | -132.99% | -335.00% | -182.73% | -47.85% | Upgrade
|
Free Cash Flow Margin | -133.33% | -119.07% | -286.00% | -166.19% | - | Upgrade
|
EBITDA | -178 | -251 | -333 | -208 | - | Upgrade
|
EBITDA Margin | -134.85% | -129.38% | - | -149.64% | - | Upgrade
|
D&A For EBITDA | 1 | 1 | 1 | 3 | - | Upgrade
|
EBIT | -179 | -252 | -334 | -211 | -85 | Upgrade
|
EBIT Margin | -135.61% | -129.90% | - | -151.80% | -40.67% | Upgrade
|
Effective Tax Rate | 20.98% | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.